MyWealthGrowth.com logo
HomeMutual Funds

Nippon India Pharma Fund

Nippon India Pharma Fund

Regular PlanGrowth Option

Fund Performance

Lumpsum

SIP

23.55

as on 19 May 2022

3 Years

Investment of ₹ 10,000 in this fund 3 Years back would be ₹ 18,890 today.

Invest Now

NAV Performance

Nippon India Pharma Fund performance graph for last 3 years
Performance of Nippon India Pharma Fund for last 3 Years

Fund Information

  • ₹ 266.097

    as on 19 May 2022
  • Regular - Growth

  • -

  • ₹ 5,000

  • ₹ 5,224 Cr.

    as on 31 Dec 2021
  • 2%

  • 02 Jan 2013

  • Equity - Sectoral/Thematic

  • S&P BSE Healthcare TRI

  • Nippon India Mutual Fund

    Show All Funds
  • Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.

Highlights of this fund

Nippon India Pharma Fund is an Open-ended Equity Fund. The fund belongs to Sectoral/Thematic category, where the investment is done in predominantly in stocks that are listed on Stock Exchanges like the Bombay Stock Exchange (BSE) or the National Stock Exchange (NSE) in India as well as Global stock exchanges like the Dow Jones, London Stock Exchange or LSE etc. This fund was started on 02 Jan 2013. This fund is offered by one of the top AMC (Assets Management Company) Nippon India Mutual Fund. You can also view here all other Equity funds offered by Nippon India Mutual Fund.

Latest NAV of the fund is ₹ 266.097 as on 19 May 2022.

This fund has 9 years of track record. Since 30 Nov 2021 expense ratio of this fund is 2%. Ideally you shoulds compare this fund with the benchmark S&P BSE Healthcare TRI.

You can invest in this fund in SIP with the minimum investment of ₹ 100. Lumpsum invest is offered with minimum investment of ₹ 5,000.

Fund Objective

To generate consistent returns by investing in equity,equity related of fixed income securities of Pharma and other associated companies.

List of Fund Managers of Nippon India Pharma Fund

  • About Sailesh Raj Bhan

    Picture of Sailesh Raj BhanMr. Sailesh Raj Bhan has over 24 years of experience in Indian Equity Markets with over 15 years at Reliance Nippon Life Asset Management Limited in Fund Management. He manages the flagship diversified equity schemes like Reliance Multi Cap Fund (previously Reliance Equity Opportunities Fund) - a strategy with assets of over Rs10,000cr ($1.5bn) since its inception in March 2005 and Reliance Large Cap Fund (previously Reliance Top200 Fund) – with assets of over Rs13000cr (over $1.8bn) since its inception 2007. Sailesh also manages the Largest Pharma Sector Fund in India since its inception 15 years back in May 2004, in addition to managing Reliance Consumption Fund – a broad based Consumption Thematic product since 2004. He also advises on international mandates for some strategies for the last 5 years.

Riskometer : Risk associated with this fund

Investors understand that their principal will be at High Risk

Fund Return Comparison

Fund Name 1 Month 3 Months 6 Months 1 Year 2 Years 3 Years 5 Years 10 Years 1 Year 2 Years 3 Years 5 Years 10 Years
Category Best 0.04% 11.29% 17.99% 24.34% 78.08% 32.55% 26.81% 22.01% 34.55% 48.85% 44.27% 28.80% 21.94%
Category Average -7.84% -6.76% -10.68% 5.61% 36.06% 15.18% 10.10% 13.94% -9.44% 15.71% 17.67% 12.95% 12.69%
Nippon India Pharma Fund -8.38%₹ 9,161 -5.39%₹ 9,461 -11.82%₹ 8,818 -8.53%₹ 9,147 -18.43%₹ 10,776 22.85%₹ 15,091 4.29%₹ 25,076 23.55%₹ 18,890 17.80%₹ 46,786 15.77%₹ 20,807 17.17%₹ 92,092 16.76%₹ 47,155 14.59%₹ 2,57,351
Quant Infrastructure Fund -11.11%₹ 8,889 -6.11%₹ 9,389 -6.69%₹ 9,330 21.23%₹ 12,123 5.22%₹ 12,334 76.51%₹ 31,156 48.85%₹ 37,223 32.55%₹ 23,341 44.27%₹ 66,510 19.83%₹ 24,721 28.80%₹ 1,21,859 14.85%₹ 39,981 19.31%₹ 3,31,771
ICICI Prudential Technology Fund -9.84%₹ 9,015 -14.90%₹ 8,509 -21.01%₹ 7,899 15.77%₹ 11,576 -20.74%₹ 10,617 62.78%₹ 26,496 25.31%₹ 30,587 30.80%₹ 22,429 34.52%₹ 58,705 26.57%₹ 32,503 28.61%₹ 1,21,323 22.01%₹ 73,215 21.94%₹ 3,82,411
Quant Consumption Fund -10.63%₹ 8,937 -6.34%₹ 9,366 -10.26%₹ 8,974 12.35%₹ 11,235 -6.57%₹ 11,573 56.28%₹ 24,422 31.48%₹ 32,280 29.58%₹ 21,804 35.43%₹ 59,411 16.38%₹ 21,357 23.86%₹ 1,08,305 17.79%₹ 51,499 19.74%₹ 3,39,483
Aditya Birla Sun Life Digital India Fund -10.93%₹ 8,906 -15.08%₹ 8,491 -19.46%₹ 8,054 11.19%₹ 11,118 -21.99%₹ 10,530 51.46%₹ 22,939 19.88%₹ 29,126 29.08%₹ 21,552 29.35%₹ 54,825 25.84%₹ 31,578 26.10%₹ 1,14,280 20.61%₹ 65,225 20.94%₹ 3,62,318
Tata Digital India Fund -11.48%₹ 8,851 -15.36%₹ 8,464 -20.84%₹ 7,916 14.21%₹ 11,420 -21.39%₹ 10,572 53.45%₹ 23,547 21.71%₹ 29,615 26.77%₹ 20,414 29.59%₹ 55,000 26.81%₹ 32,813 26.39%₹ 1,15,089 - -

Portfolio Holdings

Portfolio holdings pattern of Nippon India Pharma Fund as on 21 May 2022 are listed below:

  • Equity Holdings:

    99.12%
  • Debt Holdings:

    0.00%
  • Others Holdings:

    0.88%

Top Sector Holdings of Nippon India Pharma Fund

Name of SectorHolding PercentageHolding Values in Crore
Pharmaceuticals 76.57% ₹ 4,131.98 Cr.
Hospital 16.57% ₹ 894.34 Cr.
Healthcare service providers 5.47% ₹ 295.34 Cr.
Medical equipment & supplies 0.51% ₹ 27.79 Cr.
Others .88% -

Top Stock Holdings of Nippon India Pharma Fund

Name of StocksHolding PercentageHolding Values in Crore
Sun Pharmaceutical Industries Ltd. 11.91% ₹ 642.82 Cr.
Dr. Reddys Laboratories Ltd. 9.55% ₹ 515.24 Cr.
Cipla Ltd. 8.75% ₹ 472.05 Cr.
Aurobindo Pharma Ltd. 7.62% ₹ 411.24 Cr.
Lupin Ltd. 7.40% ₹ 399.32 Cr.
Others 54.77% -

Other Holdings

Holding TypeHolding Percentage
TREPS 1.17%
Margin 0.17%
Net Receivables -0.46%